Etoxidol, 50 mg/ml 5 ml 10 pcs
It is an inhibitor of free radical processes, has membranoprotective, antihypoxic, nootropic, anticonvulsant, anxiolytic effect, increases resistance to stress. It has anti-ischemic properties, improves blood flow in the area of ischemia, limits the area of ischemic damage, has hypolipidemic effect, reduces the content of total cholesterol and low density lipoproteins.
It increases resistance of the body to various damaging factors, to oxygen-dependent pathological states (shock, hypoxia and ischemia, cerebral circulatory disorders, intoxication with alcohol and antipsychotic drugs (neuroleptics).
The effectiveness in encephalopathies is due to the penetration of ethoxidol through the blood-brain barrier. It improves cerebral metabolism and blood supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation.
Inhibits lipid peroxidation, increases superoxide dismutase activity, reduces total organic peroxides, increases lipid-protein ratio, reduces membrane viscosity, increases its fluidity. It blocks oxidation of low density lipoproteins.
Modulates the activity of membrane-bound enzymes (calcium independent phosphodiesterase, adenylate cyclase, acetylcholinesterase), receptor complexes (benzodiazepine, GABA, acetylcholine), which helps to maintain the structural and functional organization of biomembranes, transport of neurotransmitters and improves synaptic transmission.
When administered in m/m, it is determined in plasma for 4 hours after administration. TCmax – 0.25 h. T1/2 – 1.15-1.75 h. It is excreted by the kidneys, mainly in glucuron-conjugated form and in small amounts unchanged.
Acute cerebral circulation disorders,
autonomic dystonia syndrome,
mild cognitive disorders of atherosclerotic genesis,
anxiety disorders in neurotic and neurosis-like conditions,
relieving withdrawal syndrome in alcoholism with a predominance of neurosis-like and autonomic-vascular disorders,
acute intoxication with antipsychotic agents.
1 ml of solution for intravenous and intramuscular administration contains:
the active substance:
ethylmethylhydroxypyridine malate (ethoxidol) 50 mg.
N-acetyl-L-glutamic acid 34 mg,
Deanol (2-(dimethylamino)ethanol) 16 mg,
Glycine 0.1 mg,
dinatrium edetate (dinatrium ethylenediamine-N,N,N’,N’-tetraacetic acid 2-water [trilon B] salt) 0.5 mg,
water for injection up to 1.0 ml
How to take, the dosage
The drug is administered intramuscularly (i.m.) and intravenously (i.v.) (by trickle or drip). During infusion the drug should be diluted in 0.9% sodium chloride solution. Doses shall be selected individually. Start with – 50-100 mg 1-3 times per day, gradually increasing until therapeutic effect is achieved. Slowly by jetting for – 5-7 minutes, or by drip at a rate of 40-60 drops per minute. The maximum dose is 800 mg/day.
In acute disorders of cerebral circulation: in complex therapy in the first 2-4 days v/v (dropwise) – 200-300 mg, then in a/m – 100 mg 3 times/day, 10-14 days.
In dyscirculatory encephalopathy in the decompensation phase and vegetative dystonia syndrome: by IV stream or dropwise – 100 mg 2-3 times/day, 14 days. Then v/m, – 100 mg 2 times/day, 14 days.
For course prophylaxis of dyscirculatory encephalopathy: in/m, – 100 mg 2 times/day, 10-14 days.
In mild cognitive impairment of atherosclerotic genesis and in anxiety disorders with neurotic and neurosis-like conditions: in/m, – 100-300 mg/day, 14-30 days.
When relieving withdrawal syndrome in alcoholism with predominance of neurosis-like and vegetative-vascular disorders: in/m – 100-200 mg 2-3 times/day or by IV drops – 1-2 times/day, 5-7 days.
In acute intoxication with antipsychotic drugs: v/v, – 50-300 mg/day, 7-14 days.
It enhances the effect of benzodiazepine anxiolytics, anticonvulsants (carbamazepine), antiparkinsonian drugs (levodopa).
During treatment, caution should be exercised when driving vehicles and engaging in other potentially dangerous activities that require high concentration and rapid psychomotor reactions.
Hypersensitivity, acute hepatic and/or renal failure, pregnancy, lactation, age under 18 years.
With caution: Allergic diseases and reactions in the anamnesis.
Dryness, a “metallic” taste in the mouth, a sensation of “spreading heat” throughout the body, throat and chest discomfort, a feeling of lack of air (usually associated with excessive speed of administration and short-term), with prolonged use – nausea, flatulence, sleep disorders (drowsiness or difficulty falling asleep).
Due to the low toxicity of the drug, overdose is unlikely. In case of accidental overdose, symptoms of sleep disturbance may occur – somnolence, insomnia.
The treatment is symptomatic.
Ethoxidol is contraindicated in pregnancy and lactation, because strictly controlled clinical studies of the safety of the drug in pregnancy and lactation have not been conducted.
|Conditions of storage|
In the light-protected place at a temperature not exceeding 25 ° C.
Sintez OAO, Russia
Buy Etoxidol, 50 mg/ml 5 ml 10 pcs with delivery to USA, UK, Europe and over 120 other countries.